Product Information

BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2174 per EA under NDC 70954041230. Its NADAC has been published 230 times since Jun 29, 2022.

FDA first approved this application on Nov 4, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Bisoprolol Fumarate and Hydrochlorothiazide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB

Bisoprolol Fumarate and Hydrochlorothiazide
$0.2174per EA
Low Outlier

Strength

2.5; 6.25 mg/1; mg/1

NDC

70954041230

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215562

FDA Approved

11/4/2021

TE Code

AB

On Market Since

11/4/2021

Pharmacological Classes

Adrenergic beta-Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides
beta-Adrenergic Blocker

Price Statistics

The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has been published 230 times since Jun 29, 2022, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2174 per EA
All-time high$0.3594 (Jul 13, 2022)
All-time low$0.1729 (Nov 20, 2024)
52-week high$0.2223
52-week low$0.1855
Median price$0.2204
Average price$0.2402
Largest weekly change+63.0% (Nov 22, 2023)
Weeks tracked230
Tracking sinceJun 29, 2022

Price History

1W

-2.2%

1M

+1.9%

3M

+1.3%

6M

+15.5%

1Y

+4.5%

3Y

+5.8%

5Y

N/A

All

-39.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, manufactured by ANI Pharmaceuticals, Inc., is $0.2174 per EA (NDC 70954041230), effective Nov 18, 2026.

How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB changed over time?

Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has declined 39.5%. It has been tracked across 230 weekly CMS publications since Jun 29, 2022.

What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

Since Jun 29, 2022, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has ranged from a low of $0.1729 (Nov 20, 2024) to a high of $0.3594 (Jul 13, 2022), with a median of $0.2204 per EA.

Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, is $0.2138 per EA — about 2% below BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB.

Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB (NDC 70954041230) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.